Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karin Haustermans

Showing results (201-210 of 285) with videos related to

Pageof 29
Sort By:
Acta Oncologica (Stockholm, Sweden)|August 22, 2019
Radiation dose and pathological response in oesophageal cancer patients treated with neoadjuvant chemoradiotherapy followed by surgery: a multi-institutional analysisMelissa Thomas, Alicia S Borggreve, Peter S N van Rossum, et al.
Clinical and Translational Radiation Oncology|March 5, 2026
ESTRO consensus guidelines on GTV delineation and dose-escalation in rectal cancerGiuditta Chiloiro, Angela Romano, Regina Beets-Tan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 8, 2018
Contouring of prostate tumors on multiparametric MRI: Evaluation of clinical delineations in a multicenter radiotherapy trialMarcel A van Schie, Cuong V Dinh, Petra J van Houdt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2011
Biomarkers for cetuximab-based neoadjuvant radiochemotherapy in locally advanced rectal cancerPeter P Grimminger, Peter Danenberg, Kathrin Dellas, et al.
European Urology|October 27, 2015
Assessing the Optimal Timing for Early Salvage Radiation Therapy in Patients with Prostate-specific Antigen Rise After Radical ProstatectomyNicola Fossati, R Jeffrey Karnes, Cesare Cozzarini, et al.
The Lancet. Oncology|May 4, 2020
Outcome measures in multimodal rectal cancer trialsEmmanouil Fokas, Robert Glynne-Jones, Ane Appelt, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 13, 2023
From once-weekly to semi-weekly whole prostate gland stereotactic radiotherapy with focal boosting: Primary endpoint analysis of the multicenter phase II hypo-FLAME 2.0 trialLisa De Cock, Cédric Draulans, Floris J Pos, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 22, 2019
The 2017 Assisi Think Tank Meeting on rectal cancer: A positioning paperVincenzo Valentini, Corrie Marijnen, Geerard Beets, et al.
BJU International|January 26, 2019
Readressing the rationale of irradiation in stage I seminoma guidelines: a critical essayCharlien Berghen, Maarten Albersen, Pierre Blanchard, et al.
European Urology|December 26, 2021
Patterns of Failure Following External Beam Radiotherapy With or Without an Additional Focal Boost in the Randomized Controlled FLAME Trial for Localized Prostate CancerVeerle H Groen, Karin Haustermans, Floris J Pos, et al.
Pageof 29

Showing results (201-210 of 285) with videos related to

Sort By:
Pageof 29
Acta Oncologica (Stockholm, Sweden)|August 22, 2019
Radiation dose and pathological response in oesophageal cancer patients treated with neoadjuvant chemoradiotherapy followed by surgery: a multi-institutional analysisMelissa Thomas, Alicia S Borggreve, Peter S N van Rossum, et al.
Clinical and Translational Radiation Oncology|March 5, 2026
ESTRO consensus guidelines on GTV delineation and dose-escalation in rectal cancerGiuditta Chiloiro, Angela Romano, Regina Beets-Tan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 8, 2018
Contouring of prostate tumors on multiparametric MRI: Evaluation of clinical delineations in a multicenter radiotherapy trialMarcel A van Schie, Cuong V Dinh, Petra J van Houdt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2011
Biomarkers for cetuximab-based neoadjuvant radiochemotherapy in locally advanced rectal cancerPeter P Grimminger, Peter Danenberg, Kathrin Dellas, et al.
European Urology|October 27, 2015
Assessing the Optimal Timing for Early Salvage Radiation Therapy in Patients with Prostate-specific Antigen Rise After Radical ProstatectomyNicola Fossati, R Jeffrey Karnes, Cesare Cozzarini, et al.
The Lancet. Oncology|May 4, 2020
Outcome measures in multimodal rectal cancer trialsEmmanouil Fokas, Robert Glynne-Jones, Ane Appelt, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 13, 2023
From once-weekly to semi-weekly whole prostate gland stereotactic radiotherapy with focal boosting: Primary endpoint analysis of the multicenter phase II hypo-FLAME 2.0 trialLisa De Cock, Cédric Draulans, Floris J Pos, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 22, 2019
The 2017 Assisi Think Tank Meeting on rectal cancer: A positioning paperVincenzo Valentini, Corrie Marijnen, Geerard Beets, et al.
BJU International|January 26, 2019
Readressing the rationale of irradiation in stage I seminoma guidelines: a critical essayCharlien Berghen, Maarten Albersen, Pierre Blanchard, et al.
European Urology|December 26, 2021
Patterns of Failure Following External Beam Radiotherapy With or Without an Additional Focal Boost in the Randomized Controlled FLAME Trial for Localized Prostate CancerVeerle H Groen, Karin Haustermans, Floris J Pos, et al.
Pageof 29